BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/06/2014

FDA Clears AZO GANTANOL and AZO GANTRISIN for Sale

The FDA has determined that two urinary tract medications, AZO GANTANOL and AZO GANTRISIN, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →